BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 17184232)

  • 1. Plasminogen activators and inhibitor type-1 in alveolar osteitis.
    Serratì S; Margheri F; Bruschi S; D'Alessio S; Pucci M; Fibbi G; Tonelli P; Del Rosso M
    Eur J Oral Sci; 2006 Dec; 114(6):500-3. PubMed ID: 17184232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
    Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
    Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 by grape seed proanthocyanidin extract.
    Sandra D; Radha M; Harishkumar M; Yuichi N; Sayuri O; Masugi M
    Phytomedicine; 2010 Jan; 17(1):42-6. PubMed ID: 19640694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in pericardial morphology and fibrinolytic activity during cardiopulmonary bypass.
    Nkere UU; Whawell SA; Thompson EM; Thompson JN; Taylor KM
    J Thorac Cardiovasc Surg; 1993 Aug; 106(2):339-45. PubMed ID: 8341074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system.
    Fibbi G; D'Alessio S; Pucci M; Cerletti M; Del Rosso M
    Biol Chem; 2002 Jan; 383(1):127-36. PubMed ID: 11928807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of urokinase type plasminogen activator, plasminogen activator inhibitor type 1 and activated protein C in fibrinolysis of human placenta.
    Moniwa N
    Pol J Pharmacol; 1996; 48(2):215-20. PubMed ID: 9112654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretion of fibrinolytic enzymes facilitates human mesenchymal stem cell invasion into fibrin clots.
    Neuss S; Schneider RK; Tietze L; Knüchel R; Jahnen-Dechent W
    Cells Tissues Organs; 2010; 191(1):36-46. PubMed ID: 19390164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2007; 119(4):475-80. PubMed ID: 16828495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells.
    Sprague LD; Tomaso H; Mengele K; Schilling D; Bayer C; Stadler P; Schmitt M; Molls M
    Oncol Rep; 2007 May; 17(5):1259-68. PubMed ID: 17390074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator system in oral squamous cell carcinoma.
    Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
    Br J Oral Maxillofac Surg; 2007 Dec; 45(8):623-7. PubMed ID: 17590247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood urokinase plasminogen activator system in chronic urticaria.
    Kasperska-Zajac A; Brzoza Z; Rogala B
    Arch Dermatol Res; 2007 Jan; 298(8):409-11. PubMed ID: 17102952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-urokinase: physiochemical properties and promotion of its fibrinolytic activity by urokinase and by tissue plasminogen activator with which it has a complementary mechanism of action.
    Gurewich V
    Semin Thromb Hemost; 1988 Jan; 14(1):110-5. PubMed ID: 3127884
    [No Abstract]   [Full Text] [Related]  

  • 14. Tissue type plasminogen activator facilitates NMDA-receptor-mediated retinal apoptosis through an independent fibrinolytic cascade.
    Kumada M; Niwa M; Hara A; Matsuno H; Mori H; Ueshima S; Matsuo O; Yamamoto T; Kozawa O
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1504-7. PubMed ID: 15790922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the fibrinolytic system in corneal angiogenesis.
    Vogten JM; Reijerkerk A; Meijers JC; Voest EE; Borel Rinkes IH; Gebbink MF
    Angiogenesis; 2003; 6(4):311-6. PubMed ID: 15166500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular regulation of fibrinolysis.
    Plow EF; Felez J; Miles LA
    Thromb Haemost; 1991 Jul; 66(1):32-6. PubMed ID: 1656542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase and its receptor in follicular and inflammatory cysts of the jaws.
    Serratì S; Panzardi I; Margheri F; Chillà A; Torre E; Fibbi G; Tonelli P; Del Rosso M
    Oral Dis; 2010 Nov; 16(8):753-9. PubMed ID: 20646237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptors for plasminogen activator, urokinase, in normal and Rous sarcoma virus-transformed mouse fibroblasts.
    Del Rosso M; Dini G; Fibbi G
    Cancer Res; 1985 Feb; 45(2):630-6. PubMed ID: 2981611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The urokinase plasminogen activator (uPA) system in uterine natural killer cells in the placental bed during early pregnancy.
    Naruse K; Lash GE; Bulmer JN; Innes BA; Otun HA; Searle RF; Robson SC
    Placenta; 2009 May; 30(5):398-404. PubMed ID: 19272641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of the plasminogen/plasmin system.
    Lijnen HR
    Int J Clin Lab Res; 1996; 26(1):1-6. PubMed ID: 8739849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.